|
Real-time Estimate
Cboe Europe
18:58:29 30/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 174.20 SEK | -1.14% |
|
+3.21% | +10.31% |
| 09-28 | Better Collective tumbles on weak Stockholm exchange, OMXS30 index down 0.5% | FW |
| 09-28 | Stockholm bourse mixed at midday, Better Collective plunges | FW |
Company Valuation: CellaVision AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 7,757 | 5,462 | 5,057 | 5,188 | 3,749 | 4,203 | - | - |
| Change | - | -29.58% | -7.42% | 2.59% | -27.72% | 12.09% | - | - |
| Enterprise Value (EV) 1 | 7,763 | 5,456 | 5,000 | 5,065 | 3,587 | 4,015 | 3,979 | 3,919 |
| Change | - | -29.71% | -8.37% | 1.31% | -29.18% | 11.93% | -0.9% | -1.51% |
| P/E | 61.9x | 46.2x | 38.8x | 36.9x | 24.5x | 29.9x | 23.7x | 20.9x |
| PBR | 14.3x | 8.51x | 7.06x | 6.36x | 4.22x | 4.34x | 3.92x | 3.52x |
| PEG | - | -8.36x | 3.8x | 4.58x | 2.78x | -3.68x | 0.9x | 1.6x |
| Capitalization / Revenue | 13.7x | 8.54x | 7.47x | 7.17x | 4.94x | 5.41x | 4.8x | 4.43x |
| EV / Revenue | 13.7x | 8.53x | 7.38x | 7x | 4.73x | 5.17x | 4.54x | 4.13x |
| EV / EBITDA | 39.6x | 27.5x | 24.2x | 23.2x | 14.9x | 17.5x | 14.1x | 12.5x |
| EV / EBIT | 47.7x | 34.5x | 29.9x | 28.5x | 17.8x | 22.4x | 17.6x | 15.2x |
| EV / FCF | 68x | 81.1x | 45.1x | 41.4x | 31.4x | 37.1x | 34.8x | 27.3x |
| FCF Yield | 1.47% | 1.23% | 2.22% | 2.42% | 3.19% | 2.69% | 2.87% | 3.66% |
| Dividend per Share 2 | 2 | 2 | 2.25 | 2.5 | 2.75 | 2.75 | 3.133 | 3.4 |
| Rate of return | 0.62% | 0.87% | 1.06% | 1.15% | 1.75% | 1.56% | 1.78% | 1.93% |
| EPS 2 | 5.25 | 4.96 | 5.46 | 5.9 | 6.42 | 5.898 | 7.436 | 8.414 |
| Distribution rate | 38.1% | 40.3% | 41.2% | 42.4% | 42.8% | 46.6% | 42.1% | 40.4% |
| Net sales 1 | 565.6 | 639.3 | 677.3 | 723.2 | 759 | 777.1 | 876 | 948.1 |
| EBITDA 1 | 196.2 | 198.4 | 206.8 | 218.7 | 241.4 | 229.7 | 281.3 | 313.2 |
| EBIT 1 | 162.7 | 158.3 | 167.1 | 177.7 | 202.1 | 179.5 | 226.5 | 257 |
| Net income 1 | 125.3 | 118.3 | 130.3 | 140.7 | 153.1 | 140.7 | 179.4 | 203.4 |
| Net Debt 1 | 6.368 | -5.558 | -56.94 | -122.6 | -162.6 | -187.8 | -223.9 | -284.1 |
| Reference price 2 | 325.20 | 229.00 | 212.00 | 217.50 | 157.20 | 176.20 | 176.20 | 176.20 |
| Nbr of stocks (in thousands) | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | 23,852 | - | - |
| Announcement Date | 04/02/22 | 08/02/23 | 07/02/24 | 06/02/25 | 05/02/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 29.87x | 5.17x | 17.48x | 1.56% | 420M | |
| 33.77x | 5.9x | 22.6x | 0.27% | 251B | |
| 38.31x | 6.82x | 21.62x | 0.62% | 159B | |
| 44.67x | 11.83x | 26.11x | -.--% | 146B | |
| 16.59x | 3.4x | 11.08x | -.--% | 63.59B | |
| 34.8x | 6.97x | 22.06x | -.--% | 50.77B | |
| 34.09x | 6.74x | 22.89x | 0.59% | 49.35B | |
| 18.96x | 2.31x | 11.71x | 2.65% | 48.75B | |
| 42.65x | 10.31x | 22.72x | -.--% | 45.1B | |
| 77.6x | 7.38x | 22.48x | -.--% | 43.55B | |
| Average | 37.13x | 6.68x | 20.07x | 0.57% | 85.74B | |
| Weighted average by Cap. | 37.12x | 7.10x | 21.52x | 0.38% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CEVI Stock
- Valuation CellaVision AB
Select your edition
All financial news and data tailored to specific country editions
